Stock comparison
Haemonetics
Mettler-Toledo International
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
HAE
Haemonetics
Market cap
$2.98B
Sector
Healthcare
MTD
Mettler-Toledo International
Market cap
$22.29B
Sector
Healthcare
Overall winner
Mettler-Toledo International MTD
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | HAE | MTD | Winner |
|---|---|---|---|
| Warren Buffett | 70B | 69B | HAE |
| Benjamin Graham | 85A | 65B | HAE |
| Philip Fisher | 60C | 63C | MTD |
| Peter Lynch | 54C | 66B | MTD |
| Joel Greenblatt | 31F | 68B | MTD |
| Charlie Munger | 54D | 74B | MTD |
| Terry Smith | 55D | 70B | MTD |
Side-by-side metrics
| Metric | HAE | MTD |
|---|---|---|
| Market cap | $2.98B | $22.29B |
| P/E (TTM) | 24.8x | 25.3x |
| EV/EBIT | 14.1x | 21.6x |
| ROIC (TTM) | 8.37% | 36.09% |
| Gross margin | 55.74% | 57.79% |
| Net margin | 7.29% | 21.4% |
| Revenue CAGR 5y | 7.65% | 2.01% |
| EPS CAGR 5y | 24.62% | 6.12% |
| Debt / Equity | 1.5x | - |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
HAE leads on
- EPS CAGR 5y24.62%vs 6.12%+75%
- Revenue CAGR 5y7.65%vs 2.01%+74%
- EV/EBIT14.1xvs 21.6x+35%
MTD leads on
- Debt / Equity-vs 1.5x+103%
- Market cap$22.29Bvs $2.98B+87%
- ROIC (TTM)36.09%vs 8.37%+77%
- Net margin21.4%vs 7.29%+66%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.